SB

Sean Brusky

Chief Business Officer

Prelude Therapeutics Incorporated

Claremont, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Prelude Therapeutics Incorporated
Industry
research
Employees
140.0
Seniority
C suite
Annual Revenue
7000000.0

Technologies

Outlook Amazon AWS WP Engine Adobe Marketing Cloud Mobile Friendly Google Tag Manager WordPress.org Typekit reCAPTCHA Akamai RUM Render Remote AI

Keywords

oncology cancer therapeutics precision medicines biotech precision oncology cancer research small molecule therapies cancer biology biotechnology: pharmaceutical preparations health care biotechnology research cancer therapies clinical trials smarca2 cdk9 inhibitor targeted protein degradation next generation degrader antibody conjugates precision adcs drug discovery medicinal chemistry cancer signaling pathways biomarker-selected patients first-in-class drugs best-in-class programs high unmet need transformational cancer treatments precision medicine therapeutic targets safety & efficacy novel drug candidates cancer treatment clinical development drug candidates scientific research innovative medicines determination target class agnostic drug design regulatory pathways biomedical research clinical pharmacology patient focused research & development collaboration scalable manufacturing therapeutic utility chemical modalities small molecule inhibitors strategic partnerships scientific insights oncology diagnostics drug candidate selection drug optimization regulatory compliance hospital & health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans